Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis, has launched the REM-I Platform, a high-dimensional cell morphology analysis and sorting platform. The platform will enable new methods of discovery in a range of fields, including cancer biology, stem cell biology, gene therapy and functional screening. Deepcell’s leaders will present data on the company’s AI-based morphology profiling solutions at CYTO 2023. CEO Ramsey Masri believes that AI models will surpass the limits of what our eyes can see and peer ever more deeply into the biology of individual cells. Maddison Masaeli, PhD, cofounder and CEO of Deepcell, believes that AI will revolutionize biological research. Cell morphology was one of the first ways cells were studied since the advent of the microscope, and the REM-I Platform will enable further advancements in cellular quantification.
Add to Favourites
To login click here